Table 36:
Age,a y | Year 1, $ | Year 2, $ | Year 3, $ | Year 4, $ | Year 5, $ |
---|---|---|---|---|---|
Funding CGM Based on a Conservative Projection of a 20% Annual Increase | |||||
All ages | 13,663,640 | 16,350,489 | 19,342,798 | 22,893,882 | 27,137,269 |
0–24 | 3,846,289 | 4,602,632 | 5,444,962 | 6,444,585 | 7,639,091 |
25–65 | 7,448,947 | 8,913,725 | 10,545,030 | 12,480,958 | 14,794,307 |
65+ | 2,368,403 | 2,834,131 | 3,352,807 | 3,968,338 | 4,703,871 |
Funding CGM for Entire Population With Hypoglycemia Unawareness | |||||
All ages | 121,695,684 | 125,149,848 | 126,682,327 | 127,706,376 | 128,424,590 |
0–24 | 34,257,109 | 35,229,450 | 35,660,840 | 35,949,108 | 36,151,284 |
25–65 | 66,344,309 | 68,227,400 | 69,062,855 | 69,621,132 | 70,012,677 |
65+ | 21,094,266 | 21,692,998 | 21,958,632 | 22,136,137 | 22,260,629 |
Funding CGM for Entire Type 1 Diabetes Population | |||||
All ages | 486,782,736 | 500,599,393 | 506,729,308 | 510,825,506 | 513,308,356 |
0–24 | 137,028,436 | 140,917,800 | 142,643,359 | 143,796,431 | 144,495,349 |
25–65 | 265,377,235 | 272,909,602 | 276,251,421 | 278,484,528 | 279,838,092 |
65+ | 84,377,065 | 86,771,991 | 87,834,527 | 88,544,547 | 88,974,915 |
Abbreviations: CGM, continuous glucose monitoring; NBI, net budget impact.
Ages 0–24 years, full funding of blood glucose test strips (annual cost $1,243); 25–65 years, strips funded to a maximum of $920; 65+ years, full funding of strips and $170 grant for syringes and needles.